Abstract

  The late genes of adenovirus are transcribed from the major late transcription unit (MLTU), generating mRNA through L1 to L5. L4-33K protein is RNA splicing factor responsible for early to late switch in L1 alternative splicing. The L1-52,55K mRNA is produced during both early and late after infection, whereas L1-IIIa mRNA at late phase. L4-33K when phosphorylated by DNA-dependent protein kinase (DNA-PK) has an inhibitory effect on the temporal switch in L1 alternative RNA splicing, whereas phosphorylation with protein kinase A (PKA) has an enhancer effect on L1-IIIa splicing. The C-terminal region of L4-33K is conserved and responsible for splicing, nuclear localization and other functional activities. Mutational studies replacing serine with glycine in L4-33K, referred to as S176G, S189G, S196G did not hamper above functionality, but mutation at position 192 abolished the L4-33K splicing enhancer activity and nuclear localization. Here we show the posttranslational effect of these proteins against DNA-PK and PKA; all the mutants showed hypophosphorylation with DNA-PK and PKA, except S192G, which unusually showed hyperphosphorylation up to 2.63 times of the wild type L4-33K against DNA-PK, justifying earlier findings. This unusual result may be due to drastic misfolding of S192G exposing other phosphorylating residues. It would be interesting to carry out structural analysis of this protein during native and phosphorylated state.

Keywords: Adenovirus; L4-33K; Gene Regulation; RNA Splicing; Posttranslational Modification; DNA-PK; PKA

References

1. Biasiotto R and Akusjärvi G. “Regulation of human adenovirus alternative RNA splicing by the adenoviral L4-33K and L4-22K proteins”. International Journal of Molecular Sciences 2 (2015): 2893-2912.
2. Shaw AR and Ziff EB. “Transcripts from the adenovirus-2 major late promoter yield a single early family of 3’ coterminal mRNAs and five late families”. Cell3 (1980): 905-916.
3. Iwamoto S., et al. “Transcription unit mapping in adenovirus: regions of termination”. Journal of Virology 1 (1986): 112-119.
4. Törmänen H., et al. “L4-33K, an adenovirus-encoded alternative RNA splicing factor”. Journal of Biological Chemistry 48 (2006): 36510-36517.
5. Farley DC., et al. “Activation of the Early-Late Switch in Adenovirus Type 5 Major Late Transcription Unit Expression by L4 Gene Products”. Journal of Virology 4 (2004): 1782-1791.
6. Ewing SG., et al. “Ternary Complex Formation on the Adenovirus Packaging Sequence by the IVa2 and L4 22-Kilodalton Proteins”. Journal of Virology 22 (2007):12450-12457.
7. Lempiäinen H and Halazonetis TD. “Emerging common themes in regulation of PIKKs and PI3Ks”. The EMBO Journal 20 (2009): 3067-3073.
8. Carter T., et al. “A DNA-activated protein kinase from HeLa cell nuclei”. Molecular and Cellular Biology 12 (1990): 6460-6471.
9. Yaneva M., et al. “Interaction of DNA-dependent protein kinase with DNA and with Ku: biochemical and atomic-force microscopy studies”. The EMBO Journal 16 (1997): 5098-5112.
10. Maldonado E., et al. “A human RNA polymerase II complex associated with SRB and DNA-repair proteins”. Nature 6577 (1996): 86-89.
11. Lees-Miller SP. “The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight”. Biochemistry and Cell Biology 4 (1996): 503-512.
12. Montminy M. “Transcriptional regulation by cyclic AMP”. Annual Review of Biochemistry 1 (1997): 807-822.
13. Rannels SR and Corbin JD. “Two different intrachain cAMP binding sites of cAMP-dependent protein kinases”. Journal of Biological Chemistry 15 (1980): 7085-7088.
14. Nigg EA., et al. “Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus”. The EMBO Journal 11 (1985): 2801-2806.
15. Törmänen Persson H., et al. “Two cellular protein kinases, DNA-PK and PKA, phosphorylate the adenoviral L4-33K protein and have opposite effects on L1 alternative RNA splicing”. PLoS One2 (2012): e31871.
16. Östberg S., et al. “Serine 192 in the tiny RS repeat of the adenoviral L4-33K splicing enhancer protein is essential for function and reorganization of the protein to the periphery of viral replication centers”. Virology2 (2012): 273-281.
17. Howland JL. “Short protocols in molecular biology, third edition. Edited by F Ausubel, R Brent, R E Kingston, D D Moore, J G Seidman, J A Smith and K Struhl”. Biochemical Education 1 (1996): 68-68.
18. Morris SJ and Leppard KN. “Adenovirus Serotype 5 L4-22K and L4-33K Proteins Have Distinct Functions in Regulating Late Gene Expression”. Journal of Virology 7 (2009): 3049-3058.
19. Finnen RL., et al. “Truncation of the human adenovirus type 5 L4 33-kDa protein: evidence for an essential role of the carboxy-terminus in the viral infectious cycle”. Virology 2 (2001): 388-399.
20. Fessler SP and Young CSH. “The role of the L4 33K gene in adenovirus infection”. Virology2 (1999): 507-516.
21. Han I., et al. “EBNA-LP Associates with Cellular Proteins Including DNA-PK and HA95”. Journal of Virology 5 (2001): 2475-2481.
22. Sellis D., et al. “Phosphorylation of the arginine/serine repeats of lamin B receptor by SRPK1-insights from molecular dynamics simulations”. Biochimica et Biophysica Acta 1 (2012): 44-55.
23. Summers KC., et al. “Phosphorylation: the molecular switch of double-strand break repair”. International Journal of Proteomics (2011): 373816.
24. Pan T-C., et al. “Differential Proteomics Reveals Discrete Functions of Proteins Interacting with Hypo- versus Hyper-phosphorylated NS5A of the Hepatitis C Virus”. Journal of Proteome Research 7 (2019): 2813-2825.
25. Nishi H., et al. “Physicochemical mechanisms of protein regulation by phosphorylation”. Frontiers in Genetics 5 (2014): 270.

Citation

Citation: Mohammad Feraz Ahsan. “Anomalous Behavior of Adenovirus L4-33K Mutant Protein". Acta Scientific Microbiology 3.5 (2020): 50-54.

Copyright

Copyright: © 2020 Mohammad Feraz Ahsan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.